Aurobindo will shell out $250 million to acquire drugmaker Lannett, shoring up the Indian drugmaker’s footprint in the U.S.

Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

Image source: Getty Images. What: Shares of Lannett Company, Inc. (NYSE: LCI), a midsized generic drugmaker, packed on 25.2% last month, according to data from S&P Global Market Intelligence.

PHILADELPHIA, Aug. 25, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 fourth quarter and full year ended June 30, 2021. "With the ...

An evaluation of Lannett’s recent purchase of Kremers Urban provides insight into an appealing boost to the company’s product diversification and pipeline. A discussion of Lannett’s fall in ...

In response to reporting fiscal second-quarter results, shares of Lannett Company, Inc. (NYSE: LCI), a producer of generic drugs, fell 11% as of 3:53 p.m. EST on Thursday. Here's a look at the ...

Lannett Company has a beta of 2.74, which means that the percentage change in its stock value will be higher than the entire market in times of booms and busts.

About Lannett Company, Inc.: Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.

Welcome to the Lannett Company Fiscal 2021 Fourth Quarter and Full Year Financial Results Conference Call. My name is Adrianne, and I will be your operator for today's call.

Lannett Company, Inc. (LCI) Q2 2022 Earnings Conference Call February 3, 2022 4:30 PM ETCompany ParticipantsRobert Jaffe – Investor RelationsTim Crew – ...

Lannett Company, Inc. LCI announced that its major supplier, Jerome Stevens Pharmaceuticals (JS Pharma) will not renew their distribution agreement, which is set to expire on Mar 23, 2019.